Silence Therapeutics (SLN) Pharma and Biotech Sector

  • Latest quote

    55.40p (mid)

  • Current Change (%)

    -1.95%

  • Price

    Bid: 55.20p

    Offer: 59.80p

  • Today

    High: 55.40p

    Low: 55.40p

  • This year

    High: 205.00p

    Low: 55.40p

  • Information

    Volume: 1,000

    Market Cap: £42.46M




Silence Therapeutics RNS Feed

Title Release date
Settlement and License Agreement with Alnylam 07:00 - December 10, 2018
Erratum: Results of Placing - Withdrawn 18:29 - October 12, 2018
Results of Placing 17:12 - October 12, 2018
PTAB Upholds Silence Patent 10:14 - October 11, 2018
New divisional patent and injunction application 07:00 - October 10, 2018
Holding(s) in Company 14:16 - October 5, 2018
Additional Listing 14:19 - September 21, 2018
Interim results for six months ended 30 June 2018 07:00 - September 11, 2018
Holding(s) in Company 10:53 - August 30, 2018
Holding(s) in Company 10:46 - August 30, 2018
Notice of Results 07:00 - August 24, 2018
Silence Therapeutics Announces Board Change 09:30 - August 20, 2018
Litigation: patisiran EU MA imminent 07:00 - August 7, 2018
Director/PDMR Shareholding 15:00 - July 17, 2018
Appoints David Horn Solomon as CEO 13:00 - July 17, 2018

NOTE: This is based on 20 open tips for this company


Total Number of Share tips :

20

View all Silence Therapeutics Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today